A Phase 2A Study of ALXN1007 in Participants With Newly Diagnosed Acute Lower Gastrointestinal Graft-Versus-Host Disease
Clinical trial NCT02245412 · TERMINATED
Trial details
- NCT number
- NCT02245412
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-14
- Primary completion
- 2017-02-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.